Verification evidence is still being completed.
PDF / print export
Arctic Bioscience AS
Orsta, Norway
- Verified lead
- Christer L. Valderhaug
- Lead status
- STATUS: VERIFIED APRIL 2026
- Leadership verification
- Chief Executive Officer
- 2026 technical specialization
- Marine-Lipid Therapeutics, Herring Roe Phospholipids, and Phase IIb Psoriasis Development
- Review cycle
- 24 April 2026
- Full address
- Industrivegen 42, 6155 Orsta, Norway
- Site coordinates
- Verification evidence is still being completed.
- Editorial review
- Memel Biotech editorial review
- Official leadership source
- Arctic Bioscience people page listing Christer L. Valderhaug as Chief Executive Officer.
- Editorial note
- Orsta marine-lipid pharma with GMP clinical-material manufacturing, a Phase IIb psoriasis program on HRO350, and the commercial Romega omega-3 brand under an Oslo Bors listing.
Marine-Lipid Therapeutics, Herring Roe Phospholipids, and Phase IIb Psoriasis Development
GMP manufacturing for clinical material, Oslo Bors listing ABS, Public CEO disclosure on company site
Orsta marine-lipid pharma with GMP clinical-material manufacturing, a Phase IIb psoriasis program on HRO350, and the commercial Romega omega-3 brand under an Oslo Bors listing.
Review coverage
Leadership
Facility
Certifications
Capabilities
Partners
Sources
Quality
Editorial verificationMemel Biotech directory review sign-off
Report generated02 Jun 2026, 01:40
Company profile · Orsta, Norway
Arctic Bioscience AS
Marine-Lipid Therapeutics, Herring Roe Phospholipids, and Phase IIb Psoriasis Development · GMP clinical and commercial nutraceutical supply
Orsta marine-lipid pharma with GMP clinical-material manufacturing, a Phase IIb psoriasis program on HRO350, and the commercial Romega omega-3 brand under an Oslo Bors listing.
- Lead
- Christer L. Valderhaug (verified ↗)
- Address
- Industrivegen 42, 6155 Orsta, Norway (source ↗)
- Compliance
- GMP manufacturing for clinical material
- Last reviewed
- 24 Apr 2026 (1mo ago)
- Scale
- GMP clinical and commercial nutraceutical supply
- Capabilities
- Herring Roe Oil Extraction and Purification · Marine Omega-3 Phospholipid Manufacturing · HRO350 Phase IIb Psoriasis Program
- Founded
- 2017
- Headcount
- 11-50
- Company page (open ↗)
Clinical profileSTATUS: VERIFIED APRIL 2026
Christer L. Valderhaug
Chief Executive Officer
Full addressIndustrivegen 42, 6155 Orsta, Norway
Site coordinatesVerification evidence is still being completed.
Review cycle24 April 2026
Physical site source
Arctic Bioscience contact page listing Industrivegen 42, Orsta as the headquarters.
Open sourceGMP clinical and commercial nutraceutical supply
Orsta, Norway. Marine-Lipid Therapeutics, Herring Roe Phospholipids, and Phase IIb Psoriasis Development. Review completed on 24 Apr 2026.
Norwegian Medicines Agency and EMA for clinical program oversight
GMP manufacturing for clinical material, Oslo Bors listing ABS, Public CEO disclosure on company site
Marine-Lipid Therapeutics, Herring Roe Phospholipids, and Phase IIb Psoriasis Development
Orsta marine-lipid pharma with GMP clinical-material manufacturing, a Phase IIb psoriasis program on HRO350, and the commercial Romega omega-3 brand under an Oslo Bors listing.
Editorial note
Arctic Bioscience is an Oslo-Bors-listed (ABS) marine-biotech running a Phase IIb psoriasis trial on HRO350 and selling Romega branded omega-3 products, with GMP manufacturing of clinical material and an Oslo R&D office alongside the Orsta headquarters.
FULL TRUST REVIEW COMPLETE
Shown only when all seven trust checks are fully mapped in the directory.
Current review cycleApril 2026
Capabilities
Core capabilities
Primary declared technical activities and areas of operating focus.
Herring Roe Oil Extraction and Purification
Marine Omega-3 Phospholipid Manufacturing
HRO350 Phase IIb Psoriasis Program
Verification source dossier
Verification source dossier
Official source set used to support leadership, physical-site, certification, and watch-note evidence.
Infrastructure
Declared infrastructure
Marine lipid extraction
Phospholipid purification
Clinical trial operations
Regulatory posture
Quality system coverage
GMP / GLP / ISO-13485 / FDA-Inspected are global quality-system standards. "Verified active" means the directory confirmed the certification is current; "Review in progress" means the cert status is currently being re-verified.
- GMP
- VERIFIED ACTIVE 2026
- GLP
- REVIEW IN PROGRESS 2026
- ISO-13485
- REVIEW IN PROGRESS 2026
- FDA-Inspected
- REVIEW IN PROGRESS 2026
Verification history
Verification history
24 Apr 2026: Executive identity confirmed via official management disclosure.
24 Apr 2026: Full trust review completed.
FAQ
Frequently asked questions
- Where is Arctic Bioscience AS located?
- Arctic Bioscience AS operates from Industrivegen 42, 6155 Orsta, Norway, Orsta, Norway.
- Who runs Arctic Bioscience AS?
- Arctic Bioscience AS is led by Christer L. Valderhaug, Chief Executive Officer. Verified 24 Apr 2026.
- What certifications does Arctic Bioscience AS hold?
- Arctic Bioscience AS is documented under GMP manufacturing for clinical material.
- What does Arctic Bioscience AS do?
- Orsta marine-lipid pharma with GMP clinical-material manufacturing, a Phase IIb psoriasis program on HRO350, and the commercial Romega omega-3 brand under an Oslo Bors listing. Core capabilities: Herring Roe Oil Extraction and Purification, Marine Omega-3 Phospholipid Manufacturing, HRO350 Phase IIb Psoriasis Program.
Editorial context
Related technical briefs
Briefs that name Orsta as a covered market or city.